Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Sunitinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 12 Gastrointestinal 4 Breast 4 Tumor-Agnostic 3 Sarcoma 2 Endocrine 2 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 NET 1 Myeloid 1 Lymphoid 1 Head & Neck 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 9 Small Cell Lung Carcinoma 6 Thymoma 5 Neoplasms 3 Carcinoma, Renal Cell 3 Gastrointestinal Stromal Tumors 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Nervous System Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Head and Neck Neoplasms 1 Carcinoma 1 Brain Neoplasms 1 Adenoma, Islet Cell 1 Adenocarcinoma, Bronchiolo-Alveolar 1 Adenocarcinoma 1

Interventions

pembrolizumab 41 Carboplatin 28 Pemetrexed 23 Docetaxel 21 Nivolumab 19 Cisplatin 19 Paclitaxel 17 Gemcitabine 14 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 Specimen Handling 11 Cyclophosphamide 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 osimertinib 9 Erlotinib Hydrochloride 9 Radiosurgery 8 Cetuximab 8 Biopsy 7 Temozolomide 6 Ramucirumab 6 Radiation 6 tislelizumab 5 fludarabine 5 durvalumab 5 Trastuzumab 5 Taxes 5 Ipilimumab 5 Gefitinib 5 veliparib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02623127 2019-01-23

KOSMIC

Seoul National University Hospital

Phase 2 Completed

Neoplasm Metastasis, Recurrence, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡